Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram

por Lash, T L, Pedersen, L, Cronin-Fenton, D, Ahern, T P, Rosenberg, C L, Lunetta, K L, Silliman, R A, Hamilton-Dutoit, S, Garne, J P, Ewertz, M, Sørensen, H T
Publicado 2008